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Genome sequencing and virulence studies of 2 Jap-
anese  encephalitis  viruses  (JEVs)  from  bats  in  Yunnan, 
China, showed a close relationship with JEVs isolated from 
mosquitoes and humans in the same region over 2 decades. 
These results indicate that bats may play a role in human 
Japanese encephalitis outbreaks in this region. 
B
ats have been increasingly recognized as an important 
source of zoonotic viruses responsible for some of the 
recent major disease outbreaks, including Hendra, Nipah, 
severe acute respiratory syndrome–associated, and Ebola 
viruses (1). Japanese encephalitis virus (JEV) is a mem-
ber of the family Flaviviridae and the genus Flavivirus (2) 
and is the etiologic agent of severe encephalitic diseases 
in humans. In addition to humans, JEV has been isolated 
from various hosts, e.g., mosquitoes, birds, pigs, and horses 
(3,4). The role of bats in JEV epidemiology has been poor-
ly defined, although the virus has been isolated from bats 
of various species since 1963 in multiple locations (5,6). To 
date, no nucleotide sequence information has been avail-
able for bat JEV isolates.
Yunnan Province, in southern China, has a tropical to 
subtropical climate and a diverse biota. The annual case 
rate of Japanese encephalitis in Yunnan is >2× the aver-
age case rate of the whole country (7). We report the mo-
lecular and virulence characterization of 2 bat JEV isolates 
from Yunnan: B58, obtained from a Leschenault’s rousette 
(Rousettus leschenaultia), a fruit bat, in 1989; and GB30, 
obtained from a little tube-nosed bat (Murina aurata), an 
insectivore, in 1997.
The Study
The viruses used in this study were isolated from ho-
mogenates of the brains of bats by direct intracranial (i.c.) 
inoculation of 3-day-old suckling mice. Although isolate 
B58  was  obtained  in  1989,  no  further  identification  or 
characterization was conducted until this study. GB30 was 
identified as JEV by serologic analysis (8). Inoculation in 
suckling  mice  was  conducted  following  procedures  ap-
proved by the Animal Ethics Committee of the Institute for 
Viral Disease Control and Prevention, China. Mice were 
observed 2× per day after inoculation, and every 2 hours 
after the onset of clinical signs. After euthanasia, superna-
tant from brain homogenate was used to inoculate C6/36 
cells. After the appearance of cytopathic effect (CPE), su-
pernatant was harvested and passaged 3 more times. Virus 
stock was prepared from the previous passage and stored 
at –85oC.
Neurovirulence of the 2 bat JEV strains and of a mos-
quito-derived JEV strain, M10 (9), were determined. All 
viruses were consecutively passed 3 times in mice, and 
virus suspension (defined as the 10–1 stock) was prepared 
from the third passage. For determination of a 50% lethal 
dose (LD50), suckling mice (5 per group) were inoculated 
i.c. with dilutions from 10–1 to 10–9. Animals were moni-
tored daily for survival, and the LD50 values were calcu-
lated by using a standard method (10).
Viral RNA was isolated by using the Viral RNA Mini 
Kit (QIAGEN, Hilden, Germany). First strand cDNA was 
synthesized using the Ready-To-Go kit (Amersham Phar-
macia  Biotech,  Uppsala,  Sweden).  Flavivirus-specific 
primers (11) and primers designed from the sequence of 
JEV Beijing-1 (L48916) were used for PCR and sequenc-
ing. Sequence assembly was conducted by using the ATGC 
software package, version 4.0 (GENETYX Corp., Tokyo, 
Japan).  Homology  and  alignment  analysis  were  con-
ducted  by  using  ClustalX  version  1.8  (www.clustal.org/
download/1.X/ftp-igbmc.u-strasbg.fr/pub/ClustalX)  and 
MegAlign (DNASTAR, Madison, WI, USA). MEGA 3.1 
(12) was used for phylogenetic analysis.
For initial studies, suckling mice were inoculated i.c. 
with the supernatant of clarified brain homogenate. The 2 
groups (n = 8 for each) inoculated with B58 and GB30, re-
spectively, displayed clinical signs after 42 h postinocula-
tion (hpi), whereas the control group with buffer only (n = 
8) displayed no clinical signs. Clinical signs included refus-
ing sucking, no interest in grouping, neck rigidity, tremors 
and muscular spasms, ataxia, and hind-limb paralysis. All 
mice had to be euthanized from 70 to 78 hpi. The superna-
tant of brain homogenate was used to inoculate C6/36 cells, 
and CPE was visible at ≈96 hpi for the first passage and at 
72 hpi for second and third passages.
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sequencing. The complete genome sequence of both iso-
lates was then determined. The 2 genomes have identical 
size at 10,977 nt with a 95-nt 5′ nontranslated region (NTR) 
and a 583-nt 3′ NTR. The single open reading frame codes 
for a polyprotein of 3,432 aa. The genomes have similar 
guanine-cytosine content (51.44% for B58 and 51.39% for 
GB30).
The 2 bat JEV isolates have an overall sequence iden-
tity of 99.9% both at nt and aa levels. When compared to 55 
known JEV isolates of known complete genome sequenc-
es, the nt sequence identity varies from 88.6% to 99.3%, 
and aa sequence identity from 97.0% to 99.3%. Analysis of 
the NTR sequences showed that the bat JEV isolates have 
the same 5′ NTR as do the others, but the 3′ NTRs of the 
bat JEVs have a G insertion at nt 307, the same as that 
observed in the Nakayama strain (GenBank accession no. 
EF571853).
Phylogenetic trees derived from nucleotide sequences 
of the complete genome or the most variable envelope pro-
tein gene of selected JEV strains (Table 1) indicated that 
both JEV isolates from bats are members of genotype III as 
defined by Solomon et al. (3). A more detailed analysis in-
dicated that the bat JEVs are most closely related to human 
isolate LiYujie and mosquito isolate BN19 within cluster 
6 (Figure). Similar phylogenetic trees were obtained based 
on other gene sequences, such as PrM (data not shown).
Neurovirulence of the 2 bat JEV isolates was deter-
mined as described above, and the LD50 for suckling mice 
was 8.0 log10/0.02 mL, compared with 3.5 log10/0.02 mL 
for the mosquito strain M10. Neurovirulence of these 2 bat 
isolates also was predicted from aa sequence comparison 
to those known to have high neurovirulence (13,14). As 
shown in Table 2, all residues important for virulence and 
neurotropism were conserved between the bat JEV isolates 
and the Nakayama strain.
Conclusions
In this study, we analyzed the complete genome se-
quences of 2 bat JEV isolates.  Although previous serologic 
studies (15) have indicated the occurrence of JEV in a Le-
schenault’s rousette, we demonstrate JEV infection of Ma-
rina aurata bats, confirming that the same JEV genotype can 
infect bats of many species. Both bats are commonly present 
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Table 1. Background information of selected strains of Japanese encephalitis virus used in this study* 
Strain Source Year Location GenBank accession no. Genotype
B58 Bat 1986 China FJ185036 III
GB30 Bat 1997 China FJ185037 III
Beijing-1 Human 1949 China L48916 III
p3 Human 1949 China U47032 III
Nakayama Human 1935 Japan EF571853 III
JaOH0566 Human 1966 Japan AY508813 III
Ling Human 1965 Taiwan L78128 III
ML17-_live Human 1981 Taiwan AY508812 III
Vellore P20778 Human 1958 India AF080251 III
GP78 Human 1978 India AF0723 III
FU Human 1995 Austria AF217620 II
WHe Pig NA China EF107523 III
SA14-14-2 SA-14 derivative 1954 China AF315119 III
SA-14 Mosquito 1954 China U14163 III
SH0601 Mosquito 2006 China EF543861 III
JaGAr01 Mosquito 1959 Japan AF069076 III
Ishikawa Mosquito 1998 Japan AB051292 I
JaOArS982 Mosquito 1982 Japan M18370 III
K87P39 Mosquito 1987 South Korea AY585242 III
K94P05 Mosquito 1994 South Korea AF045551 I
RP-9 Mosquito 1985 Taiwan AF014161 III
CH2195LA NA 1994 Taiwan AF221499 III
BN19 Mosquito 1982 China FJ185038 III
Liyujie Human 1979 China FJ185039 III
YN86-86266 Mosquito 1986 China DQ404134 
 
 
I
WTP-70-22 Mosquito 1970 Malaysia D00998 II
47 Human 1950s China AY243810 III
Tla Human 1971 China AY243808 III
NACH-13 Human NA China AY243813 III
YNJH04-18 Mosquito 2004 China DQ404078 III
Chiang Mai Human 1964 Thailand U70393 III
G8924 Mosquito 1956 India EF688636 III
733913 Human 1973 India AB379813 III
782219 Human 1978 India EF688655 III
VN118 Mosquito 1979 Vietnam D00975 III
JKT7003 Mosquito 1981 Indonesia AY184215 IV
*Boldface indicates strains with complete genome sequences in GenBank. NA, information not available. JEV from Bats, China
in Yunnan Province and other parts of China. The bats tend 
to roost in trees, caves, and roofs of residential properties 
in close proximity to rice paddocks and pig pens, provid-
ing ample opportunity for cross-species transmission among 
bats and between bats and other animals. Notably, the 2 JEV 
strains most closely related to the bat viruses were all iso-
lated from Yunnan Province, LiYujie from a human in 1979 
and BN19 from mosquitoes in 1982 (Figure).
Our study indicates that the same virus is circulating in 
hosts of at least 4 different species (human, mosquito, and 2 
different bat species), and likely in birds as well, highlight-
ing the broad host range of JEVs in this area. We empha-
size that the 4 closely related strains (B58, GB30, LiYujie, 
and BN19) were isolated over 2 decades, which suggests 
that the virus was stably maintained in the region, perhaps 
by circulating in disparate hosts. The findings from our cur-
rent study highlight the potential importance of bats in hu-
man JE outbreaks in the region. Needed additional studies 
of JEV in bats should include the determination of viremia 
in bats of different species and potential seasonal variation 
of viral loads among different bats at different geographic 
locations. This data would provide a better assessment of 
risks posed by JEV in bats.
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Figure. Phylogenetic tree based on the envelope (E) protein gene 
of  selected  Japanese  encephalitis  virus  strains.  Murray  Valley 
encephalitis virus (MEV) E gene (in boldface) was used as an 
outgroup. Genotypes are indicated on the right. The 2 bat virus 
isolates  used  in  this  study  are  indicated  by  shading.  Scale  bar 
indicates number of nucleotide substitutions per site. See Table 
1 for more details of the strains used in this analysis and their 
GenBank accession numbers.
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